Dermal Fillers Market to Experience 7.8% CAGR during 2023-2030; Innovative Products Developed to Improve Facial Structures will result in Market Expansion

The global dermal fillers market size was valued at USD 5.01 billion in 2022. The market is projected to grow from USD 5.32 billion in 2023 to USD 9.00 billion by 2030, exhibiting a CAGR of 7.8% during the forecast period. Fortune Business Insights™ presents this information in its report titled “Dermal Fillers Market Size, Share & COVID-19 Impact Analysis, By Material (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, PMMA (Poly (Methyl Methacrylate)), Fat Fillers, and Others), By Product (Biodegradable and Non-Biodegradable), By Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/Fullness, and Others), By End-user (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others), and Regional Forecast, 2023-2030”. In the current environment, there has been a significant and persistent growth in demand for cosmetic procedures, particularly non-invasive ones like dermal fillers. These are injections of gel-like substances beneath the facial skin intended to provide an attractive result. These operations are anticipated to grow in procedural volumes as disposable income increases globally, especially in developing nations.

Negative Impact on Market due to Cancellation of Elective Cosmetic Procedures in COVID-19

Being at the center of this unique worldwide pandemic crisis, the healthcare industry was particularly affected by COVID-19. Being an elective surgery and one of the first medical procedures to see cancellations, the industry has been significantly impacted. Due to considerable delays in elective and non-essential treatments in a number of nations, major firms saw a loss in revenue in 2020 compared to the previous year.

Galderma Introduced Radiesse (+) Lidocaine Injectable Implants to Improve Facial Structure

Galderma introduced Radiesse (+) Lidocaine injectable implants in February 2022 for deep injection (subdermal and/or supraperiosteal) for the enhancement of soft tissue. In people over the age of 21, it improves moderate to severe loss of jawline shape.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/dermal-fillers-market-100939

Rising R&D Efforts and Increasing Dermal Filler Procedure Demand Will Boost Market Growth

The growing number of R&D initiatives for the creation of new fillers is one of the other main factors driving the global market. There are many different aesthetic benefits to these items. Market expansion is predicted to be fueled by the expansion of the application areas for various non-invasive or minimally invasive cosmetic procedures. Additionally, the numerous clinical trials conducted as a result of different R&D projects have a favorable impact on market expansion. These factors are expected to increase the global market share.

One of the main obstacles preventing the worldwide dermal fillers market growth is the hefty price tag attached to these products.

Competitive Landscape

Strong Portfolio of ALLERGAN (AbbVie, Inc.) Will Advance Business to Dominant Position

Regarding the market's competitive environment, there are a variety of players, with businesses ranging from big, well-known firms to tiny, up-and-coming ones. A significant amount of the revenue generated by the worldwide market is accounted for by ALLERGAN (AbbVie, Inc.), which dominates the industry in the current market environment. Due to its broad range of high-quality products, which include the JUVEDERM Collection of HA fillers, the company has a dominant position on the market.

Notable Industry Development:

• February 2022: Abbvie Inc. received FDA approval for JUVEDERM VOLBELLA XC for the improvement of infraorbital hollow in adults over the age of 21.

List of Key Players Profiled in the Report:

• ALLERGAN (AbbVie, Inc.) (U.S.)


• Revance Therapeutics, Inc. (U.S.)


• Merz Pharma (Germany)


• Galderma (Switzerland)


• Sinclair Pharma (U.K.)


• BIOPLUS CO., LTD. (South Korea)


• Bioxis Pharmaceuticals (France)


• SCULPT Luxury Dermal Fillers Ltd. (Czech Republic)


• DR. Korman (Israel)


• Prollenium Medical Technologies (Canada)


• Suneva Medical (U.S.)


• Anika Therapeutics, Inc. (U.S.)

Further Report Findings:

• Europe is expected to have the second-highest market share in 2022, which may be attributed to the growing demand for dermal filler operations in major European nations and the continent's expanding R&D spending.


• During the projection period, Asia Pacific is anticipated to experience the highest growth rate. The region's market is expanding as a result of the region's improved healthcare

Report Scope & Segmentation